These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 2788342

  • 1. [Circulating T cells in patients with breast or genital cancers in the pre-therapeutic phase].
    Strache RR, Büttner HH, Kunze M, Röpcke G.
    Zentralbl Gynakol; 1989; 111(12):816-23. PubMed ID: 2788342
    [Abstract] [Full Text] [Related]

  • 2. [Behavior of T-lymphocytes in patients with a gynecologic malignancy].
    Ressel M, Köhler G.
    Zentralbl Gynakol; 1984; 106(17):1192-7. PubMed ID: 6333766
    [Abstract] [Full Text] [Related]

  • 3. [Carcino-embryogenic antigen (CEA) in patients with genital tumors (author's transl)].
    Anger H, Gleissenberger U.
    Geburtshilfe Frauenheilkd; 1977 Jul; 37(7):604-8. PubMed ID: 885332
    [Abstract] [Full Text] [Related]

  • 4. T- and B-lymphocyte subpopulations in pre-invasive and invasive carcinoma of the cervix.
    Rand RJ, Jenkins DM, Bulmer R.
    Clin Exp Immunol; 1977 Dec; 30(3):421-8. PubMed ID: 304787
    [Abstract] [Full Text] [Related]

  • 5. [Carcinoembryonic antigen in gynecological oncology].
    Stiglmayer R.
    Fortschr Med; 1978 Oct 05; 96(37):1843-5. PubMed ID: 700565
    [Abstract] [Full Text] [Related]

  • 6. Serum soluble fas level as a prognostic factor in patients with gynecological malignancies.
    Konno R, Takano T, Sato S, Yajima A.
    Clin Cancer Res; 2000 Sep 05; 6(9):3576-80. PubMed ID: 10999747
    [Abstract] [Full Text] [Related]

  • 7. E-rosette forming lymphocytes in carcinoma of uterine cervix patients before and after treatment.
    Singh RP, Shukla M, Singh VP, Udupa KN.
    J Assoc Physicians India; 1987 Mar 05; 35(3):211-2. PubMed ID: 3497155
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Gynaecological and breast cancers at the Dakar Cancer Institute].
    Dem A, Traoré B, Dieng MM, Diop PS, Ouajdi T, Lalami MT, Diop M, Dangou JM, Touré P.
    Sante; 2008 Mar 05; 18(1):25-9. PubMed ID: 18684687
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. T-cell immunity to the folate receptor alpha is prevalent in women with breast or ovarian cancer.
    Knutson KL, Krco CJ, Erskine CL, Goodman K, Kelemen LE, Wettstein PJ, Low PS, Hartmann LC, Kalli KR.
    J Clin Oncol; 2006 Sep 10; 24(26):4254-61. PubMed ID: 16908932
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Dynamic sampling analysis of the immune status of breast cancer patients].
    Eremina OF, Kunitsyna TA, Sharonina AI.
    Vopr Onkol; 1985 Sep 10; 31(6):33-7. PubMed ID: 3875181
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.